SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001410578-23-001985
Filing Date
2023-08-17
Accepted
2023-08-17 16:30:51
Documents
71
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 6-K cvac-20230630x6k.htm   iXBRL 6-K 132724
2 EX-99.1 cvac-20230630xex99d1.htm   iXBRL EX-99.1 822909
3 EX-99.2 cvac-20230630xex99d2.htm EX-99.2 240968
4 GRAPHIC cvac-20230630xex99d1001.jpg GRAPHIC 9817
  Complete submission text file 0001410578-23-001985.txt   6242149

Data Files

Seq Description Document Type Size
5 EX-101.SCH cvac-20230630.xsd EX-101.SCH 95428
6 EX-101.CAL cvac-20230630_cal.xml EX-101.CAL 57971
7 EX-101.DEF cvac-20230630_def.xml EX-101.DEF 319280
8 EX-101.LAB cvac-20230630_lab.xml EX-101.LAB 646487
9 EX-101.PRE cvac-20230630_pre.xml EX-101.PRE 460090
65 EXTRACTED XBRL INSTANCE DOCUMENT cvac-20230630x6k_htm.xml XML 950169
Mailing Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076
Business Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 49 7071 9883 0
CureVac N.V. (Filer) CIK: 0001809122 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39446 | Film No.: 231182338
SIC: 2834 Pharmaceutical Preparations